Recurrent Mantle Cell Lymphoma Clinical Trials in Los Angeles

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Suspended
  • Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
  • +25 more
  • Birmingham, Alabama
  • +23 more
2022-03-05
Mar 5, 2022
J
Recruiting
  • CD19 Positive
  • +13 more
  • Chimeric Antigen Receptor T-Cell Therapy
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
2021-08-10
Aug 10, 2021
N
Completed
  • Recurrent Mantle Cell Lymphoma
  • Anaheim, California
  • +81 more
2018-10-02
Oct 2, 2018
N
Completed
  • Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
  • +6 more
  • Duarte, California
  • +4 more
2018-02-05
Feb 5, 2018
N
Terminated
  • Adult B Acute Lymphoblastic Leukemia
  • +28 more
  • Los Angeles, California
  • +6 more
2015-08-18
Aug 18, 2015
N
Completed
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +84 more
  • Duarte, California
  • +22 more
2015-06-30
Jun 30, 2015
N
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +84 more
  • sunitinib malate
  • +2 more
  • Los Angeles, California
  • +10 more
2014-03-14
Mar 14, 2014
N
Completed
  • Adult Grade III Lymphomatoid Granulomatosis
  • +62 more
  • Duarte, California
  • +10 more
2014-02-21
Feb 21, 2014